Press Releases
Investor Resources
Press Releases
Press Release
Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 p.m. EDTJune 27, 2023
Press Release
Cardiol Therapeutics Commences Multi-center Phase II Pilot Study of CardiolRx™ for the Treatment of Recurrent PericarditisDecember 12, 2022
Press Release
Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementNovember 14, 2022
Press Release
Cardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart DiseasesOctober 25, 2022